AstraZeneca to use Russian COVID-19 vaccine component in clinical trials,

Drugmaker AstraZeneca will use a component of Russia’s “Sputnik V” COVID-19 vaccine in clinical trials for its vaccine, officials said Friday., Drugmaker AstraZeneca will use a component of Russia’s “Sputnik V” COVID-19 vaccine in clinical trials for its vaccine, officials said Friday., Read More

Scroll to Top